GLPBio

Apoptosis

Read More about this category

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

 

References:

1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.

2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.

3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.

4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.

5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Research Areas

Products Related to Apoptosis(3030)

  • GN10216 structure
    GN10216Shikonin
    CAS: 517-89-5
    Purity: >98.00%

    Shikonin es un producto natural que contiene quinona. Shikonin es un potente inhibidor del canal de cloruro TMEM16A con un IC 50 de 6.5μM.

  • GN10217 structure
    GN10217Hypaconitine
    CAS: 6900-87-4
    Purity: >98.00%
  • GN10219 structure
    GN10219Ciwujianoside-B
    CAS: 114902-16-8
    Purity: >98%
  • GN10248 structure
    GN10248Hesperitin
    CAS: 520-33-2
    Purity: >98.50%

    Hesperetin is the aglycone form of hesperidin, a citrus bioflavonoid.

  • GN10249 structure
    GN10249Polyphyllin VI
    CAS: 55916-51-3
    Purity: >98.00%

    Polyphyllin VI es una saponina natural con buena biodisponibilidad oral, y desarrolla su actividad anticancerígena sobre todo al provocar la parada del ciclo celular, apoptosis y piroptosis.

  • GN10254 structure
    GN10254Ginsenoside Rc
    CAS: 11021-14-0
    Purity: >99.50%
  • GN10269 structure
    GN10269Wedelolactone
    CAS: 524-12-9
    Purity: >99.50%
  • GN10275 structure
    GN10275Protosappanin B
    CAS: 102036-29-3
    Purity: >99.00%
  • GN10280 structure
    GN10280Sinensetin
    CAS: 2306-27-6
    Purity: >98.00%
  • GN10284 structure
    GN10284Dioscin
    CAS: 19057-60-4
    Purity: >98.00%
  • GN10302 structure
    GN10302Hypericin
    CAS: 548-04-9
    Purity: >98.00%
  • GN10318 structure
    GN10318Danshensu
    CAS: 22681-72-7
    Purity: >98.00%
  • GN10321 structure
    GN10321Glycitein
    CAS: 40957-83-3
    Purity: >98.00%
  • GN10325 structure
    GN10325Nobiletin
    CAS: 478-01-3
    Purity: >99.00%

    Nobiletin es una flavona polimetoxilada extraída de plantas de cítricos. Nobiletin tiene una variedad de efectos farmacológicos, incluyendo propiedades antioxidantes, antiinflamatorias y antitumorales

  • GN10331 structure
    GN10331Polydatin
    CAS: 27208-80-6
    Purity: >98.00%

    Polydatin es un glucósido de estilo natural extraído de la medicina tradicional china Polygonum cuspidatum, y Polydatin es la forma glucósida del resveratrol

  • GN10333 structure
    GN10333Osthole
    CAS: 484-12-8
    Purity: >99.50%
  • GN10335 structure
    GN10335Mesaconitine
    CAS: 2752-64-9
    Purity: >98.50%
  • GN10341 structure
    GN10341Acetate gossypol
    CAS: 12542-36-8
    Purity: >99.00%

    Acetate gossypol is a lipid-soluble polyphenolic compound extracted from the cotton plant with antifertility, antioxidant, and anticancer properties.

  • GN10357 structure
    GN10357Parthenolide
    CAS: 20554-84-1
    Purity: >98.00%

    Parthenolide es un inhibidor de NF-κB con valores de IC 50 vpara las células Eca109, KYSE-510, SiHa y MCF-7 de approximadamente 10.3, 13.3, 8.42 y 9.54μM a 48h respectivamente.

  • GN10358 structure
    GN10358Berbamine hydrochloride
    CAS: 6078-17-7
    Purity: >98%
  • GN10360 structure
    GN10360Morroniside
    CAS: 25406-64-8
    Purity: >98.00%
  • GN10361 structure
    GN10361Pseudolaric Acid B
    CAS: 82508-31-4
    Purity: >98.00%
  • GN10370 structure
    GN10370Luteolin
    CAS: 491-70-3
    Purity: >98.00%

    Luteolin es un compuesto flavonoide con múltiples funciones como antiinflamatoria, antioxidante y anticancerígena. La luteolina es un inhibidor eficaz del factor nuclear relacionado con el factor eritroide 2 (Nrf2).

  • GN10388 structure
    GN10388Gallic acid
    CAS: 149-91-7
    Purity: >99.00%

    Gallic acid is a 3,4,5-trihydroxybenzoic acid phenolic compound with antioxidant, anti-inflammatory and antitumor activities.